SGMO vs ZION · rev $57.8M vs P/E 11, rev $354.0M
Sangamo Therapeutics Inc (SGMO) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
SGMO currently screens at market cap $74.6M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the SGMO and ZION stock pages for the full models.
Not investment advice.